Showing results (511-520 of 645) with videos related to

Sort By:
Pageof 65
Contemporary Clinical Trials Communications|April 27, 2018
The "Interval Walking in Colorectal Cancer" (I-WALK-CRC) study: Design, methods and recruitment results of a randomized controlled feasibility trialAnna Banck-Petersen, Cecilie K Olsen, Sissal S Djurhuus, et al.
Gynecologic Oncology|August 8, 2024
Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trialStuart A Ostby, Deepa Narasimhulu, Michelle A Ochs Kinney, et al.
Cancer Discovery|August 2, 2014
Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphomaDavid Chiron, Maurizio Di Liberto, Peter Martin, et al.
International Journal of Aging & Human Development|October 31, 2023
Multiple Roads to Success: A Latent Class Analysis on Successful Ageing Among Hong Kong Near-Centenarians and Centenarians (NCC)Eric Ngai-Yin Shum, Bobo Hi-Po Lau, Karen Siu-Lan Cheung, et al.
Arxiv|May 4, 2026
OpenMRF: A Modular, Vendor-Neutral Open-Source Framework for Reproducible Magnetic Resonance Fingerprinting using PulseqTom Griesler, Jannik Stebani, Sydney Kaplan, et al.
Gynecologic Oncology|September 28, 2020
Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitalsMelissa K Frey, Rana K Fowlkes, Nora M Badiner, et al.
Journal of Medical Internet Research|August 2, 2019
Implementation of a Digitally Enabled Care Pathway (Part 2): Qualitative Analysis of Experiences of Health Care ProfessionalsAlistair Connell, Georgia Black, Hugh Montgomery, et al.
The American Journal of Surgical Pathology|November 2, 2020
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological TherapyAliyah R Sohani, Matthew J Maurer, Sharmila Giri, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Leveraging BRG1 Driven Ferroptosis Resistance to Overcome Treatment ResistanceSoo-Yeon Hwang, Helgi Nikolli, Belem Yoval-Sánchez, et al.
Leukemia & Lymphoma|April 16, 2014
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomabRebecca L Elstrom, Jia Ruan, Paul J Christos, et al.
Pageof 65